Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00391001 · ClinicalTrials.gov registry record · Phase 1
Taurine in Adolescents With Bipolar Disorder
A Phase 1 study, sponsored by Cambridge Health Alliance.
- Terminated
- Registry status
- Phase 1
- Development phase
- 4
- Enrollment target
NCT00391001 is a Phase 1 study that was terminated before completion, run by Cambridge Health Alliance. The registered enrollment target is 4 participants.
The verdict
NCT00391001, a Phase 1 study, was terminated before completion, sponsored by Cambridge Health Alliance.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 4 participants
- Enrollment target
Study Summary
Recently, McLean hospital conducted a 4 month taurine study which showed a reduction in mania ratings. As a follow-up to the preliminary taurine study, and complementary to the currently ongoing double-blind, placebo-controlled trial for taurine in adults with bipolar disorder, this study will target adolescent bipolar subjects (type I) with symptoms of mania or mixed mania. To our knowledge, this would be the first study to evaluate the effects of the novel compound taurine in adolescent subjects with bipolar disorder. We hypothesize there will be a positive response in some adolescents from taurine treatment, and this positive response will be greater than that expected by chance. This study may demonstrate that taurine is a well-tolerated and effective adjunct treatment for mania in bipolar disorder.
Interventions
- DRUG Taurine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2006-02 |
| Est. Completion | 2007-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00391001
The ClinicalTrials.gov registry entry for NCT00391001 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cambridge Health Alliance, which has 45 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Taurine is the first listed.
NCT00391001 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00391001 about?
NCT00391001 is a clinical study titled "Taurine in Adolescents With Bipolar Disorder". Recently, McLean hospital conducted a 4 month taurine study which showed a reduction in mania ratings. As a follow-up to the preliminary taurine study, and complementary to the currently ongoing double-blind, placebo-controlled trial for taurine in adults with bipolar disorder, this study will targe...
What is the current status of trial NCT00391001?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 4 participants. The study started on 2006-02. Estimated completion is 2007-08.
What interventions are being tested in trial NCT00391001?
The interventions under investigation include: Taurine (DRUG).
Who is sponsoring clinical trial NCT00391001?
This trial is sponsored by Cambridge Health Alliance, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.